OPACIFICATION AND BORDER DELINEATION IMPROVEMENT IN PATIENTS WITH SUBOPTIMAL ENDOCARDIAL BORDER DEFINITION IN ROUTINE ECHOCARDIOGRAPHY - RESULTS OF THE PHASE-III ALBUNEX MULTICENTER TRIAL
Citation
Lj. Crouse et al., OPACIFICATION AND BORDER DELINEATION IMPROVEMENT IN PATIENTS WITH SUBOPTIMAL ENDOCARDIAL BORDER DEFINITION IN ROUTINE ECHOCARDIOGRAPHY - RESULTS OF THE PHASE-III ALBUNEX MULTICENTER TRIAL, Journal of the American College of Cardiology, 22(5), 1993, pp. 1494-1500
Categorie Soggetti
Cardiac & Cardiovascular System
SICI code
0735-1097(1993)22:5<1494:OABDII>2.0.ZU;2-S
Abstract
Objectives. This study was designed to assess the safety and efficacy
of intravenously administered sonicated human serum albumin for enhanc
ing echocardiographic delineation of the left ventricular endocardium
and improving assessment of wall motion in patients with incomplete de
piction of noncontrast echocardiography. Background. Echocardiographic
regional wall motion analysis is impaired by incomplete endocardial d
efinition in as many as 10% of patients. Sonicated human serum albumin
is a stable contrast material that, unlike other agents, opacifies th
e left ventricle when administered intravenously. Methods. One hundred
seventy-five patients were enrolled at eight centers on the basis of
incomplete echocardiographic endocardial depiction. Sonicated 5% human
serum albumin, a stable preparation of air filled microspheres (size
range 1 to 10 mu m), was administered intravenously in divided doses:
0.08 ml/kg body weight in all patients, followed by 0.14 and 0.08 ml/k
g or a single dose of 0.22 ml/kg, depending on the result of the initi
al dose. Investigators and independent reviewers blinded to the protoc
ol scored the echocardiograms for degree of left ventricular opacifica
tion and improvement of endocardial border depiction. Results. Overall
, 81% of patients had at least moderate left ventricular chamber opaci
fication with at least one contrast dose, and endocardial definition w
as improved in 83%; In the subgroup with inadequate left ventricular o
pacification from the initial dose, a second, larger dose (0.22 ml/kg)
improved endocardial depiction in 64%. No significant side effects oc
curred. Conclusions. In patients with incomplete echocardiographic end
ocardial definition, sonicated human serum albumin is a safe, effectiv
e contrast agent that, when administered intravenously, produces left
ventricular chamber opacification, improves endocardial depiction and
enhances regional wall motion analysis.